Universidad El Bosque, Bogotá
13
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Fluoride Caries-control Effectiveness/Feasibility in Children
Role: lead
Pandemic-adapted Caries Care Multicentre Single-group Interventional Study
Role: lead
Comparison of the Effectiveness of Hypochlorous Acid and Chlorhexidine as a Post-surgical Antimicrobial Agent
Role: lead
Effectiveness of an ICCMS™ Caries Management Program.
Role: lead
Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery
Role: collaborator
Cor Adv Flap Plus Ac Derm Matrix in Thin Phenotype Multiple Recessions
Role: collaborator
Horizontal Ridge Augmentation in Mandible Usign ROG + ESWT
Role: lead
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
Role: lead
HYPOCHLOROUS ACID SUBSTANTIVITY AS ANTIPLAQUE AGENT (HOCl-SAP)
Role: lead
Comparison Between Two Coronally Positioned Flap With Connective Tissue
Role: lead
Venous Ulcer Treatment With Foam Versus Conservative Treatment
Role: collaborator
Radiographic Progression of Sealed and Infiltrated Caries Lesions in Vivo
Role: lead
Evaluation of an Electro-stimulator for the Treatment of Xerostomia
Role: collaborator
All 13 trials loaded